Pay for performance for antibiotic timing in pneumonia: caveat emptor
Jesse M Pines1, Judd E Hollander, Elizabeth M Datner
1Department of Emergency Medicine, University of Pennsylvania, Philadelphia, USA. pinesjes@uphs.upenn.edu
Joint Commission Journal on Quality and Patient Safety
|November 9, 2007
Summary
Pay-for-performance initiatives for community-acquired pneumonia (CAP) may improve antibiotic timing but risk patient care delays and inappropriate antibiotic use. Optimizing emergency department workflow is key to balancing early antibiotic administration with patient safety and preventing antibiotic resistance.
Area of Science:
- Healthcare Management
- Infectious Diseases
- Clinical Performance Measures
Background:
- Hospitals and healthcare providers are preparing for a pay-for-performance program focused on antibiotic timing for community-acquired pneumonia (CAP).
- Early antibiotic administration in CAP is linked to better patient outcomes, even when accounting for disease severity.
Purpose of the Study:
- To evaluate the potential benefits and risks of performance measures for antibiotic timing in CAP.
- To explore the impact of emergency department (ED) functioning and crowding on adherence to antibiotic timing protocols.
- To identify alternative performance measures related to system throughput and workflow that correlate with improved patient care outcomes.
Main Methods:
- Analysis of existing literature and healthcare system data related to CAP management and performance metrics.
- Evaluation of the association between ED operational efficiency and the timely administration of antibiotics.
- Assessment of the potential consequences of performance pressure on antibiotic prescribing practices and patient prioritization.
Main Results:
- While early antibiotics can improve outcomes for some CAP patients, concurrent risks include delayed care for others and inappropriate antibiotic selection to meet timing targets.
- Emergency department crowding and overall system functioning significantly influence the ability to meet antibiotic timing performance measures.
- Empirical antibiotic use before diagnosis may increase rates of antibiotic administration for non-responsive conditions, potentially exacerbating antibiotic resistance.
Conclusions:
- Performance measures focused solely on antibiotic timing for CAP may inadvertently lead to negative consequences, including patient harm and increased antibiotic resistance.
- Improving ED system throughput and workflow efficiency is crucial for enhancing patient care and achieving desired outcomes in CAP management.
- Future performance measures should consider broader system-level factors beyond just antibiotic administration time to ensure patient safety and effective treatment.
Related Concept Videos
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
00:57Antibiotic Selection
Overview